How are growth hormone and insulin-like growth factor-1 reported as markers for drug effectiveness in clinical acromegaly research? A comprehensive methodologic review
ConclusionsThe way GH and IGF-1 are measured and reported in acromegaly research varies considerably. A consensus on how to report study results would enable better comparisons between studies, thereby improving evidence based decision making to optimize treatment in acromegaly.
Source: Pituitary - Category: Endocrinology Source Type: research
More News: Acromegaly | Clinical Trials | Endocrinology | Hormones | Insulin | Rare Diseases | Statistics | Study